Joy Mitra

Title: Innovations by Inventor Joy Mitra

Introduction

Joy Mitra is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of mitochondrial dysfunction treatments through his innovative research and patented technologies. His work focuses on developing novel therapies that address oxidative and metal-related toxicities.

Latest Patents

Joy Mitra holds a patent for "Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof." This patent includes modified hydrophilic carbon clusters (HCCs), poly(ethylene glycol)-hydrophilic carbon clusters (PEG-HCCs), and similarly structured materials like graphene quantum dots (GQDs) and PEGylated small molecule antioxidants. These materials have been enhanced with an iron chelating moiety, deferoxamine, or a similar chelating moiety. By utilizing common binding sites, the carbon nanostructure facilitates intracellular transport, particularly in mitochondria. This innovation reduces oxidative breakdown of the chelator moiety prior to treatment and mitigates both the causes and consequences of metal-induced oxidative stress within the body. This provides a novel form of therapy for a range of oxidative and metal-related toxicities.

Career Highlights

Throughout his career, Joy Mitra has worked with prestigious institutions such as William Marsh Rice University and the University of Texas System. His research has garnered attention for its potential to revolutionize treatments for mitochondrial dysfunction.

Collaborations

Joy has collaborated with notable colleagues, including James Mitchell Tour and Lizanne Nilewski, who have contributed to his research endeavors.

Conclusion

Joy Mitra's innovative work in the field of mitochondrial dysfunction treatments showcases his dedication to advancing medical science. His patented technologies hold promise for improving therapies related to oxidative and metal-related toxicities.